MY8700517A - Stabilised opthalmic formulation - Google Patents

Stabilised opthalmic formulation

Info

Publication number: MY8700517A
Authority: MY; Malaysia
Prior art keywords: stabilised; opthalmic; formulation; opthalmic formulation; stabilised opthalmic
Prior art date: 1980-03-21

Application number

MY517/87A

Other languages

English (en)

Inventor

Marsden Peter Hugh

Reader Michael John

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-03-21

Filing date

1987-12-30

Publication date

1987-12-31

1987-12-30 Application filed by Wellcome Found filed Critical Wellcome Found

1987-12-31 Publication of MY8700517A publication Critical patent/MY8700517A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MY517/87A 1980-03-21 1987-12-30 Stabilised opthalmic formulation MY8700517A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB8009589		1980-03-21

Publications (1)

Publication Number	Publication Date
MY8700517A true MY8700517A (en)	1987-12-31

Family

ID=10512277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MY517/87A MY8700517A (en)	1980-03-21	1987-12-30	Stabilised opthalmic formulation

Country Status (30)

Country	Link
EP (1)	EP0037043B1 (xx)
JP (1)	JPS56150012A (xx)
KR (1)	KR830004856A (xx)
AU (1)	AU542560B2 (xx)
CA (1)	CA1168154A (xx)
CS (1)	CS261206B2 (xx)
CY (1)	CY1361A (xx)
DD (1)	DD157535A5 (xx)
DE (1)	DE3167270D1 (xx)
DK (1)	DK159414C (xx)
EG (1)	EG15051A (xx)
FI (1)	FI75991C (xx)
GB (1)	GB2072015B (xx)
GR (1)	GR73038B (xx)
HK (1)	HK52787A (xx)
HU (1)	HU185630B (xx)
IE (1)	IE51035B1 (xx)
IL (1)	IL62447A (xx)
IN (1)	IN153498B (xx)
IT (1)	IT8148073A0 (xx)
MC (1)	MC1379A1 (xx)
MY (1)	MY8700517A (xx)
NO (1)	NO155377C (xx)
NZ (1)	NZ196571A (xx)
PH (1)	PH17800A (xx)
PL (1)	PL138377B1 (xx)
PT (1)	PT72703B (xx)
SG (1)	SG20787G (xx)
ZA (1)	ZA811896B (xx)
ZW (1)	ZW6481A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS62277323A (ja) *	1986-02-19	1987-12-02	Sankyo Co Ltd	フマル酸ケトチフエン含有点眼液の製法
IL80298A (en) *	1986-10-14	1993-01-31	Res & Dev Co Ltd	Eye drops
FR2622112A1 (fr) *	1987-10-27	1989-04-28	Medipro	Medicament comprenant l'association de polymyxine b, de neomycine et d'amphotericine b administre par vaporisation
ES2012532A6 (es) *	1988-07-15	1990-04-01	Cusi Lab	Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
JPH05503527A (ja) *	1990-02-22	1993-06-10	マクノート・ピーティーワイ・リミテッド	人工涙液
DE4229494A1 (de) *	1992-09-04	1994-03-10	Basotherm Gmbh	Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
ES2079994B1 (es) *	1992-10-07	1996-08-01	Cusi Lab	Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
SI1687019T1 (en)	2003-11-20	2018-04-30	Novo Nordisk A/S	Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
EA019867B1 (ru) *	2007-10-08	2014-06-30	Фовея Фармасьютикалс	Водные офтальмологические препараты
CN118903386A (zh)	2017-08-24	2024-11-08	诺和诺德股份有限公司	Glp-1组合物及其用途
BR112022013746A2 (pt)	2020-02-18	2022-10-11	Novo Nordisk As	Formulação aquosa de cagrilintida, formulação aquosa de semaglutida, dispositivo médico, e, combinação de dose fixa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2703777A (en) *	1950-05-02	1955-03-08	Iso Sol Company Inc	Ophthalmological preparations and vehicles and method of making the same
GB1340517A (en) *	1969-12-01	1973-12-12	Burton Parsons Chemicals Inc	Ophthalmic solution
US3898330A (en) *	1973-08-01	1975-08-05	Squibb & Sons Inc	Corticosteroid phosphate salts/neomycin sulfate ophthalmic
NL7416636A (nl) *	1973-12-27	1975-07-01	Wellcome Found	Farmaceutisch preparaat.

1981
- 1981-03-20 CS CS812056A patent/CS261206B2/cs unknown
- 1981-03-20 DD DD81228491A patent/DD157535A5/de not_active IP Right Cessation
- 1981-03-20 PT PT72703A patent/PT72703B/pt unknown
- 1981-03-20 ZA ZA00811896A patent/ZA811896B/xx unknown
- 1981-03-20 PH PH25391A patent/PH17800A/en unknown
- 1981-03-20 PL PL1981230236A patent/PL138377B1/pl unknown
- 1981-03-20 ZW ZW64/81A patent/ZW6481A1/xx unknown
- 1981-03-20 EP EP81102132A patent/EP0037043B1/en not_active Expired
- 1981-03-20 JP JP4662981A patent/JPS56150012A/ja active Granted
- 1981-03-20 NO NO810961A patent/NO155377C/no not_active IP Right Cessation
- 1981-03-20 CY CY136181A patent/CY1361A/xx unknown
- 1981-03-20 HU HU81723A patent/HU185630B/hu unknown
- 1981-03-20 MC MC811508A patent/MC1379A1/xx unknown
- 1981-03-20 KR KR1019810000921A patent/KR830004856A/ko unknown
- 1981-03-20 NZ NZ196571A patent/NZ196571A/xx unknown
- 1981-03-20 DK DK127181A patent/DK159414C/da not_active IP Right Cessation
- 1981-03-20 IE IE617/81A patent/IE51035B1/en not_active IP Right Cessation
- 1981-03-20 GR GR64460A patent/GR73038B/el unknown
- 1981-03-20 GB GB8108806A patent/GB2072015B/en not_active Expired
- 1981-03-20 CA CA000373477A patent/CA1168154A/en not_active Expired
- 1981-03-20 FI FI810870A patent/FI75991C/fi not_active IP Right Cessation
- 1981-03-20 DE DE8181102132T patent/DE3167270D1/de not_active Expired
- 1981-03-20 AU AU68567/81A patent/AU542560B2/en not_active Expired
- 1981-03-20 IL IL62447A patent/IL62447A/xx not_active IP Right Cessation
- 1981-03-20 IT IT8148073A patent/IT8148073A0/it unknown
- 1981-03-21 EG EG155/81A patent/EG15051A/xx active
- 1981-03-21 IN IN306/CAL/81A patent/IN153498B/en unknown
1987
- 1987-02-26 SG SG207/87A patent/SG20787G/en unknown
- 1987-07-09 HK HK527/87A patent/HK52787A/xx not_active IP Right Cessation
- 1987-12-30 MY MY517/87A patent/MY8700517A/xx unknown

Also Published As

Publication number	Publication date
CS205681A2 (en)	1988-05-16
CA1168154A (en)	1984-05-29
FI810870L (fi)	1981-09-22
PL138377B1 (en)	1986-09-30
DK159414C (da)	1991-03-18
PL230236A1 (en)	1983-07-04
DD157535A5 (de)	1982-11-17
AU6856781A (en)	1981-09-24
SG20787G (en)	1987-07-10
NO810961L (no)	1981-09-22
KR830004856A (ko)	1983-07-20
DK159414B (da)	1990-10-15
IL62447A0 (en)	1981-05-20
NZ196571A (en)	1983-03-15
IL62447A (en)	1983-11-30
JPH0148246B2 (xx)	1989-10-18
GB2072015A (en)	1981-09-30
EG15051A (en)	1985-06-30
EP0037043A1 (en)	1981-10-07
HK52787A (en)	1987-07-17
MC1379A1 (fr)	1982-01-19
ZA811896B (en)	1982-10-27
CY1361A (en)	1987-08-07
ZW6481A1 (en)	1983-01-19
PT72703B (en)	1982-11-15
AU542560B2 (en)	1985-02-28
IE51035B1 (en)	1986-09-17
EP0037043B1 (en)	1984-11-21
IN153498B (xx)	1984-07-21
GB2072015B (en)	1983-12-21
PH17800A (en)	1984-12-13
FI75991B (fi)	1988-05-31
CS261206B2 (en)	1989-01-12
FI75991C (fi)	1988-09-09
IT8148073A0 (it)	1981-03-20
DK127181A (da)	1981-09-22
PT72703A (en)	1981-04-01
NO155377B (no)	1986-12-15
DE3167270D1 (en)	1985-01-03
HU185630B (en)	1985-03-28
IE810617L (en)	1981-09-21
GR73038B (xx)	1984-01-26
JPS56150012A (en)	1981-11-20
NO155377C (no)	1987-03-25

Publication	Publication Date	Title
DE3172028D1 (en)	1985-10-03	Pharmaceutical formulation
ZA833066B (en)	1983-07-27	Pour-on formulation
MY8700517A (en)	1987-12-31	Stabilised opthalmic formulation
GB2117638B (en)	1986-10-29	Pour-on formulation
JPS56139420A (en)	1981-10-30	Drug
GB2074028B (en)	1983-09-21	Pharmaceutical formulations
MTP884B (en)	1984-06-05	Pharmaceutical preparationes
ZA817572B (en)	1982-11-24	Pharmaceutical formulation
JPS56127505A (en)	1981-10-06	Vibrator
ZA808097B (en)	1982-01-27	Novel insulin formulations
GB2115261B (en)	1985-10-09	Levelling device
JPS5784057A (en)	1982-05-26	Vibrator
GB8326445D0 (en)	1983-11-02	Levelling procedures
KE3697A (en)	1987-03-13	Stabilised ophthalmic formulation
JPS573647A (en)	1982-01-09	Vibrator
JPS56136554A (en)	1981-10-24	Vibrator
GB2014601B (en)	1982-07-21	Stabilised 111-trichloroethane
JPS5767512A (en)	1982-04-24	Ophthalmic composition
GB8316135D0 (en)	1983-07-20	Formulation
JPS56136686A (en)	1981-10-26	Vibrator
JPS573646A (en)	1982-01-09	Vibrator
AU541447B2 (en)	1980-11-21	Pour-on formulation
KE3581A (en)	1986-01-17	Pharmaceutical formulation
AU88661S (en)	1984-04-26	Levelling implement
DK173981A (da)	1981-10-18	Fremgangsmaade til fremstilling af cis-9-(3-(3,5-dimethyl-1-piperazinyl) propyl) carbazol eller salte deraf og mallemprodukter for fremstillingen